![(PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer (PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer](https://i1.rgstatic.net/publication/328429879_Application_of_the_HTA_Core_Model_for_complex_evaluation_of_the_effectiveness_and_quality_of_Radium-223_treatment_in_patients_with_metastatic_castration_resistant_prostate_cancer/links/5fc4668c299bf104cf9403ca/largepreview.png)
(PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer
![PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer](https://www.researchgate.net/profile/Beata-Gavurova/publication/328429879/figure/tbl3/AS:698276693147648@1543493545077/Finished-Radium-223-treatment-according-to-the-real-number-of-applications_Q320.jpg)
PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer
![PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer](https://www.researchgate.net/profile/Beata-Gavurova/publication/328429879/figure/fig1/AS:698276688953360@1543493544983/Representation-of-districts-in-Radium-223-therapy-in-the-INMM-Explanation-to_Q320.jpg)
PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer
![PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer PDF) Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer](https://i1.rgstatic.net/ii/profile.image/1156753265831936-1652802878181_Q64/Vladimir-Rogalewicz-2.jpg)